44 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
strategic growth plan and continue the development of its proprietary programs; the COVID-19 pandemic and any future epidemic diseases could adversely
8-K
EX-99.1
kopf3lwxfu24 6p36
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
1hcsf
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
sxcpa
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
123wlqk w1e9y
21 Jun 22
Regulation FD Disclosure
6:19am
425
w4oooo8ceeipi270w47
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
c2nl6q
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
enucz
24 Mar 22
Business combination disclosure
9:09am
8-K
z7gik1n6gfcby
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.1
67ppwmxjx bh276lfe
23 Mar 22
Business combination disclosure
5:29pm
425
2qo27rh
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
2dldnpj 58ojma
23 Mar 22
Business combination disclosure
5:29pm
8-K
gzzv tlb8g9
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm